Advertisement

Picture Berlin Partner Events Bionnale 2025 May HealthCapital 650x100px
Document › Details

CoreMedic GmbH. (1/10/25). "Press Release: CoreMedic Announces Partnership with InnoRa for Clinical Development of Transcatheter Mitral Valve Repair Device ChordArt". Basel & Philadelphia, PA.

Organisations Organisation CoreMedic GmbH
  Organisation 2 InnoRa GmbH
Products Product ChordArt Transcatheter Mitral Valve repair system (TMVr system)
  Product 2 clinical research services
     


CoreMedic GmbH has entered into a strategic partnership with InnoRa GmbH, Berlin, to accelerate clinical development of its transcatheter mitral valve repair solution ChordArt.

InnoRa GmbH contributes over 20 years of experience in the development of innovative cardiovascular devices and their translation into clinical trials to the partnership. The partnership also includes an undisclosed investment by InnoRa. Professor Bruno Scheller, a renowned expert in interventional cardiology and co-founder of InnoRa will join the Supervisory Board of CoreMedic.

Josef Bogenschütz, CEO of Coremedic GmbH, stated: “We are thrilled to embark on our partnership with InnoRa. We are developing ChordArt™ to offer a superior catheter-based therapy solution for the large and growing population of patients suffering from degenerative mitral valve regurgitation. Under our new partnership, we will jointly deploy our complementary resources to accelerate clinical development of ChordArt.

Jodi Akin, Chairwoman of the Supervisory Board of CoreMedic GmbH stated: “Professor Scheller is a globally renowned expert in interventional cardiology. This comes at the exciting inflection point of our First in Human clinical trial in Europe. We are delighted that Professor Scheller will join the Supervisory Board of CoreMedic and contribute his outstanding scientific and clinical expertise to the company.”


About CoreMedic GmbH

CoreMedic GmbH is an innovative cardiology company, located in Radolfzell, Germany. As a spin-off of the Heart Center of University of Bern, Switzerland, CoreMedic was initiated in 2012 to develop the breakthrough treatment concept for mitral valve regurgitation ChordArt. The company is backed by a group of experienced and committed private investors with backgrounds in heart medicine and cardiovascular devices and institutional healthcare investor SHS Capital.


About InnoRa GmbH

InnoRa is a German medical device company headquartered in Berlin that specializes in the research, development and manufacturing of coated balloon catheters, stents and other medical devices. InnoRa has been providing innovative solutions to improve the life quality of patients for over two decades. Founded in 2001 by scientists as a spin-off of Charité University Hospital, Berlin, Germany, InnoRa´s top priorities are research, development and the provision of high-quality services in the field of cardiovascular innovations.


About ChordArt

The ChordArt Transcatheter Mitral Valve repair (TMVr) - System is designed to improve chorda repair procedures across all crucial parameters. These include the reduction of patient trauma, duration of procedure and complexity as well as operator dependency and time of recovery for the patient. ChordArt is a catheter designed to deliver implants percutaneously allowing interventions in high-risk as well as asymptomatic patients, which are not eligible for treatment with the current "Gold Standard" of chordal replacement via open-heart surgery.


For further information, please visit www.coremedic.de or feel free to contact us via [email protected] or under +49 173 8821 359.


PR Contact

Josef Bogenschütz
CEO / Managing Director
CoreMedic GmbH
Fritz-Reichle-Ring 2
78315 Radolfzell
GERMANY

   
Record changed: 2025-01-21

Advertisement

Picture EBD Group ChinaBio Partnering Forum 2025 Shanghai 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group BIO-Europe Spring 2025 Milan to 28 Feb 650x300px




» top